Literature DB >> 3145065

Pulmonary toxicity of malaria prophylaxis.

A C Davidson1, C Bateman, C Shovlin, M Marrinan, G H Burton, I R Cameron.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145065      PMCID: PMC1834720          DOI: 10.1136/bmj.297.6658.1240

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Systemic reaction to pyrimethamine-sulfadoxine.

Authors:  R L Murphy; J P Phair
Journal:  J Fam Pract       Date:  1986-04       Impact factor: 0.493

2.  Presumptive fatality due to pyrimethamine-sulfadoxine.

Authors:  D Whitfield
Journal:  Lancet       Date:  1982-12-04       Impact factor: 79.321

3.  Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar).

Authors:  M Svanbom; L Rombo; L Gustafsson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-23

4.  [Eosinophilic lung infiltration during malaria prophylaxis with pyrimethamine-sulfadoxine (Fansidar)].

Authors:  P Buser; J Räber
Journal:  Schweiz Med Wochenschr       Date:  1985-08-24

5.  Fansidar hypersensitivity pneumonitis.

Authors:  D McCormack; W K Morgan
Journal:  Br J Dis Chest       Date:  1987-04
  5 in total
  3 in total

Review 1.  Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs.

Authors:  P A Phillips-Howard; A B Bjorkman
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Eosinophilic pneumonia induced by dapsone.

Authors:  D Jaffuel; B Lebel; D Hillaire-Buys; J Pene; P Godard; F B Michel; J P Blayac; J Bousquet; P Demolyi
Journal:  BMJ       Date:  1998-07-18

3.  The Dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations.

Authors:  Semaan G Kosseifi; Bhuvana Guha; Dima N Nassour; David S Chi; Guha Krishnaswamy
Journal:  J Occup Med Toxicol       Date:  2006-06-06       Impact factor: 2.646

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.